Skip to main content

Financial news

The newsroom

Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are written automatically by software from each headline and up to 600 characters of the feed's description, not by an editor, and are not checked against the text. They are neutral and information-only, Kresmion publishes no buy or sell recommendations. New SEC filings, and Bank of England and Bank of Japan items, carry no note.

Public RSS feeds · refreshed every 30 minutes

8814 items from SEC EDGAR · filings · clear filters

  • SEC EDGAR•filings
    8-K - ACORN ENERGY, INC. (0000880984) (Filer)

    Automated noteAcorn Energy, Inc. filed a Form 8-K on August 6, 2026, reporting results of operations and financial condition (Item 2.02) and providing financial statements and exhibits (Item 9.01).

  • SEC EDGAR•filings
    8-K - MARKETWISE, INC. (0001805651) (Filer)

    Automated noteMarketwise, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - INVESTORS TITLE CO (0000720858) (Filer)

    Automated noteInvestors Title Co filed a Form 8-K on August 6, 2026, disclosing its results of operations and financial condition and providing its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Praxis Precision Medicines, Inc. (0001689548) (Filer)

    Automated notePraxis Precision Medicines, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition, providing a Regulation FD disclosure, and attaching related financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Stran & Company, Inc. (0001872525) (Filer)

    Automated noteStran & Company, Inc. filed a Form 8-K on August 6, 2026, containing a Regulation FD disclosure (Item 7.01) and its financial statements and related exhibits (Item 9.01).

  • SEC EDGAR•filings
    8-K - CION Investment Corp (0001534254) (Filer)

    Automated noteCION Investment Corp filed a Form 8-K on August 6, 2026 (Accession No. 0001104659-26-091692), reporting its results of operations and financial condition, providing a Regulation FD disclosure, and including its financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Ocugen, Inc. (0001372299) (Filer)

    Automated noteOcugen, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Agassi Sports Entertainment Corp. (0000930245) (Filer)

    Automated noteAgassi Sports Entertainment Corp. filed a Form 8-K with the SEC on August 6, 2026, containing a Regulation FD disclosure and the company’s financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - OLENOX INDUSTRIES INC. (0001023994) (Filer)

    Automated noteOlenox Industries Inc. filed a Form 8-K reporting a notice of delisting or failure to meet a continued listing rule and a transfer of its listing, accompanied by Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - AEMETIS, INC (0000738214) (Filer)

    Automated noteAemetis, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition, providing a Regulation FD disclosure, and attaching financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - CG Oncology, Inc. (0001991792) (Filer)

    Automated noteCG Oncology, Inc. submitted a Form 8-K on August 6, 2026 (Accession No. 0001193125-26-336886), containing Item 2.02 results of operations and financial condition, Item 8.01 other events, and Item 9.01 financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Arteris, Inc. (0001667011) (Filer)

    Automated noteArteris, Inc. filed a Form 8-K on August 6, 2026, reporting departures and appointments of directors and officers, related compensatory arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Vystar Corp (0001308027) (Filer)

    Automated noteVystar Corp filed an 8-K reporting entry into a material definitive agreement, completion of an acquisition or asset disposition, unregistered sales of equity securities, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - MAXIMUS, INC. (0001032220) (Filer)

    Automated noteMaximus Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and including financial statements and related exhibits. The filing, accession number 0001032220-26-000033, is 661 KB.

  • SEC EDGAR•filings
    8-K - ONCOR ELECTRIC DELIVERY CO LLC (0001193311) (Filer)

    Automated noteOncor Electric Delivery Co LLC filed a Form 8-K on August 6, 2026, reporting results of operations and financial condition, providing a Regulation FD disclosure, and attaching financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Ensysce Biosciences, Inc. (0001716947) (Filer)

    Automated noteEnsysce Biosciences filed an 8-K reporting entry into a material definitive agreement, completion of an asset acquisition/disposition, unregistered equity sales, modifications to security holder rights, changes in directors/officers and compensation, and amendments to its charter and fiscal year.

  • SEC EDGAR•filings
    8-K - Annexon, Inc. (0001528115) (Filer)

    Automated noteAnnexon, Inc. filed a Form 8-K on August 6, 2026, reporting other events under Item 8.01 and providing its financial statements and related exhibits under Item 9.01.

  • SEC EDGAR•filings
    8-K - CRA INTERNATIONAL, INC. (0001053706) (Filer)

    Automated noteCRA International, Inc. filed a Form 8-K on August 6, 2026, reporting results of operations and financial condition, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Filer)

    Automated noteCorbus Pharmaceuticals Holdings filed a Form 8-K on August 6, 2026, containing Item 2.02 (results of operations and financial condition), Item 7.01 (Regulation FD disclosure), and Item 9.01 (financial statements and exhibits).

  • SEC EDGAR•filings
    8-K - Vivani Medical, Inc. (0001266806) (Filer)

    Automated noteVivani Medical, Inc. filed a Form 8-K on August 6, 2026, containing a Regulation FD disclosure and accompanying financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - HELIX ENERGY SOLUTIONS GROUP INC (0000866829) (Filer)

    Automated noteHelix Energy Solutions Group Inc filed a Form 8-K on August 6 2026, including Item 2.02 results of operations and financial condition, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Edgewise Therapeutics, Inc. (0001710072) (Filer)

    Automated noteEdgewise Therapeutics filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and including its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - VivoSim Labs, INC. (0001497253) (Filer)

    Automated noteVivoSim Labs, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - ALX ONCOLOGY HOLDINGS INC (0001810182) (Filer)

    Automated noteALX Oncology Holdings Inc filed a Form 8-K on August 6, 2026, including Item 2.02 on results of operations and financial condition and Item 9.01 containing financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - LIFETIME BRANDS, INC (0000874396) (Filer)

    Automated noteLifetime Brands filed an 8-K on August 6, 2026, reporting its results of operations and financial condition and including financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Filer)

    Automated noteEstablishment Labs Holdings Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 reporting its results of operations and financial condition, and Item 9.01 containing its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - ACI WORLDWIDE, INC. (0000935036) (Filer)

    Automated noteACI Worldwide, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition, providing a Regulation FD disclosure, and attaching financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - MBX Biosciences, Inc. (0001776111) (Filer)

    Automated noteMBX Biosciences, Inc. filed an 8-K on August 6, 2026, containing Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - INSIGHT ENTERPRISES INC (0000932696) (Filer)

    Automated noteInsight Enterprises Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - NOVAVAX INC (0001000694) (Filer)

    Automated noteNovavax Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 covering its results of operations and financial condition and Item 9.01 containing its financial statements and related exhibits.